Amicogen, Inc. (092040.KQ)
KOSDAQ · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩915 (+0.11%) as of
Key statistics
- Market cap
- 64.46B
- Dividend yield
- 0.00%
- 52-week range
- 787.00 – 3,325.00
- Beta
- 0.16
- Revenue (TTM)
- 46.69B
- Profit margin
- -41.33%
- Volume
- 199.49k
About Amicogen, Inc.
Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products. In addition, the company offers oral incurable and rare disease treatments, as well as manufactures and sells of pharmaceutical raw materials, animal drugs, human drugs, etc. The company was incorporated in 2000 and is headquartered in Jinju-Si, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Jinju-Si, South Korea
- Employees
- 217
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.